References
Buckingham, R.H., Grentzmann, G., and Kisselev, L.,Mol. Microbiol., 1997, vol. 24, pp. 449–456.
Kisselev, L. and Frolova, L.,Biokhimiya, 1999, vol. 64, pp. 14–24.
Frolova, L., Le Goff, X., Rasmussen, H.H., Cheperegin, S., Drugeon, G., Kress, M., Arman, I., Haenni, A.-L., Celis, J.E., Philippe, M., Justesen, J., and Kisselev, L.,Nature, 1994, vol. 372, pp. 701–703.
Song, H., Mugnier, P., Das, A.K., Webb, H.M., Evans, D.R., Tuite, M.F., Hemmings, B.A., and Barford, D.,Cell, 2000, vol. 100, pp. 311–321.
Frolova, L., Tsivkovskii, R., Sivolobova, G., Oparina, N., Serpinsky, O., Blinov, V., Tatkov, S., and Kisselev, L.,RNA, 1999, vol. 5, pp. 1014–1020.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Seit Nebi, A., Frolova, L., Ivanova, N. et al. Substitutions of the Glutamine Residue in the ubiquitous GGQ tripeptide in human eRF1 do not entirely abolish the release factor activity. Mol Biol 34, 764–765 (2000). https://doi.org/10.1007/BF02759621
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02759621